Source comparison
Bremelanotide Same as PT-141: Comparison by Context
Molecular Formula C₅₀H₆₈N₁₄O₁₀ None. Identical compound Amino Acid Sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH None. Exact sequence match Mechanism of Action MC3R/MC4R melanocortin receptor agonist None. Same receptor targets Typical Purity (Research-G
This comparison does not assign a generated winner or score.
- Molecular Formula
- C₅₀H₆₈N₁₄O₁₀
- None. Identical compound
- Amino Acid Sequence
- Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
- None. Exact sequence match
- Mechanism of Action
- MC3R/MC4R melanocortin receptor agonist
- None. Same receptor targets
- Typical Purity (Research-Grade)
- ≥98% by HPLC
- Name doesn't dictate purity; supplier QC does
- Regulatory Status
- Used in preclinical/Phase I-II studies
- INN assigned for Phase III/FDA approval
- Context-dependent labeling only
- Supplier Market
- Research peptide vendors
- Pharmaceutical/clinical suppliers
- Both supply bremelanotide same as PT-141